Table 2—

Relative risks for CHD events in type 2 diabetic patients with serum zinc level of 14.1 μmol/l or less compared with patients with serum-zinc level above 14.1 μmol/l

CHD mortality
CHD mortality or nonfatal MI
RR (95% CI)PRR (95% CI)P
Unadjusted1.80 (1.30–2.49)<0.0011.40 (1.06–1.84)0.019
Adjusted for age and sex1.81 (1.30–2.51)<0.0011.40 (1.06–1.85)0.017
Adjusted for multiple factors*1.70 (1.21–2.38)0.0021.37 (1.03–1.82)0.033
  • *

    * Adjusted for age, sex, duration of diabetes, total cholesterol level, HDL cholesterol level, triglyceride level, HbA1, estimated GFR, presence of hypertension, smoking, BMI, area of residence, and type of diabetes therapy.